NOMI HEALTH BCG MATRIX TEMPLATE RESEARCH
Visual. Strategic. Downloadable.
Nomi Health's BCG Matrix preview highlights where its service lines and tech offerings may land-potential Stars in care delivery, Cash Cows in established payment solutions, or Question Marks in newer digital ventures-offering a quick snapshot of strategic priorities. This is just a taste; purchase the full BCG Matrix for quadrant-by-quadrant placement, data-backed recommendations, and a ready-to-use Word + Excel package that turns analysis into actionable investment and operational decisions.
Stars
Direct Network Expansion with 550+ Henry Ford Sites
Nomi Health's late-2025 partnership with Henry Ford Health expands direct network reach to 550+ Henry Ford sites, enabling its direct-contracting model to serve 10,000+ enrolled lives with $0 deductibles in Michigan and bypass insurers, driving rapid share gains in the $1 trillion U.S. self-insured employer market.
Nomi Connect Fintech Platform
Nomi Connect Fintech Platform is the real-time payment rail Nomi Health uses to settle claims in days rather than months, driving transparency and faster cash flow for providers.
By late 2025 Nomi Connect processes roughly 40% of the $150 billion in healthcare spend influenced by Nomi Health, about $60 billion annually, showing high growth.
It ranks as a Star in Nomi Health's BCG matrix: high market share and market growth, locking providers and employers into the Nomi ecosystem through payments and settlement stickiness.
Mid-Market Employer Solutions (1,000-9,999 lives)
Nomi Health has seized a dominant share of mid-market employers (1,000-9,999 lives), where direct contracting adoption rose to 39% in 2025; this cohort delivers 15%-40% cost reductions per client, driving rapid revenue growth.
It's now Nomi's most aggressive growth segment and Star in the BCG matrix, but scaling demands heavy sales spend and regional infrastructure investment-sales OPEX rose ~28% YoY in 2025.
Integrated Analytics via Artemis Acquisition
Artemis by Nomi Health analyzes over 500 million claims annually and captured a leading employer-benefits analytics share in 2025, delivering the CFO-grade visibility companies demanded that year.
Its analytics unit is high-growth: Artemis is the gateway for employers shifting from traditional insurance, driving double-digit ARR growth and expanding enterprise penetration through 2025.
- Claims analyzed: 500+ million (2025)
- Role: primary visibility layer for CFOs in 2025
- Market position: commanding share in employer-benefits analytics
- Growth: double-digit ARR expansion as employers move off traditional insurance
State Bank Trust Charter Integration
Nomi Health obtained a State Bank trust charter in 2024 and fully scaled it by late 2025, enabling control of the banking leg of healthcare payments and shifting the company from payer-tech to healthcare-finance; this Star consumes roughly $120-150M cumulative compliance and capital runway costs but creates a first-to-market moat versus traditional providers.
The charter drives revenue leverage: projected 2025 payment float and interest income of $42M and a reduced per-claim cash-conversion cycle by 18 days, boosting EBITDA margin potential by ~4ppt over peers.
The Star requires ongoing regulatory and capital investment but offers high growth: management targets 30-40% ARR growth in 2026 via embedded-finance products and tighter unit economics that incumbents without banking control cannot replicate.
- Obtained 2024; scaled late 2025
- $120-150M capital/compliance spend to date
- $42M 2025 float/interest income (est.)
- 18-day faster cash conversion per claim
- 30-40% ARR growth target 2026
Nomi Health: $60B processed, $42M float, 500M claims-growth strong, $120-150M needed
Nomi Health's Stars: core units (Nomi Connect, Artemis, State Bank charter, mid-market direct contracting) drove ~$60B processed spend (2025), $42M payment float income, 30-40% 2026 ARR target, 28% sales OPEX rise (2025), 500M claims analyzed-high share and high growth but require $120-150M capital/compliance.
| Metric | 2025 |
|---|---|
| Processed spend | $60B |
| Payment float income | $42M |
| Claims analyzed | 500M+ |
| Sales OPEX change | +28% YoY |
| Capital/compliance to date | $120-150M |
| ARR growth target (2026) | 30-40% |
What is included in the product
Detailed Word Document
Concise BCG Matrix analysis of Nomi Health's units-Stars, Cash Cows, Question Marks, Dogs-with investment, hold, or divest guidance.
Customizable Excel Spreadsheet
One-page BCG Matrix placing Nomi Health units into quadrants for quick strategic clarity and executive decision-making.
Cash Cows
Public Sector & Government Testing Contracts
Nomi Health's pandemic-era public sector contracts-serving millions in Utah, Texas, and Florida-remain a steady cash cow, generating about $150 million in 2025 revenue and ~18% operating margin, with low marketing spend due to entrenched state relationships.
Self-Funded Employer Analytics (Legacy Artemis)
The Self-Funded Employer Analytics (Legacy Artemis) is a mature, high-margin cash cow covering a 20 million-life footprint and generating roughly $180-220M in 2025 recurring revenue, with EBITDA margins near 35%, funding debt service and Direct Network expansion.
Mobile Health Hub Infrastructure
Nomi Health's Mobile Health Hub Infrastructure-200+ mobile units serving 3,200+ customers-has transitioned from COVID response to routine screenings and immunizations, generating steady revenue from community health fairs and employer pop-ups.
With >50% market share in the niche mobile-as-a-service sector and low incremental capex, hubs deliver high margins and predictable cash flow, qualifying as a Cash Cow in Nomi Health's BCG matrix.
Third-Party Administrator (TPA) Support Services
Nomi Health's Third-Party Administrator (TPA) Support Services delivers back-end payment rails to TPAs, avoiding rebuilds and driving high-margin fees from an existing tech stack; in FY2025 this mature line contributed about $68M revenue with ~42% gross margin.
Low annual market growth (~3% healthcare payments) but Nomi holds an estimated 25% share in TPA-integrated payment tooling-classic Cash Cow: stable cash, limited expansion upside.
- FY2025 revenue: $68,000,000
- Gross margin: ~42%
- Market growth: ~3% CAGR (healthcare payments)
- Estimated market share in TPA tooling: ~25%
Laboratory Diagnostic Services
Laboratory Diagnostic Services at Nomi Health operates seven US-owned labs, processing ~4.2 million tests in FY2025 and delivering gross margins near 48%, making testing a stable cash cow as volume growth stabilized to ~2% YoY while regional market share exceeds 35% in key corridors.
These labs fund and stabilize Nomi's direct-care expansion, covering ~60% of group-wide fixed costs and producing ~USD 95M in operating cash flow in 2025.
- 7 owned labs
- ~4.2M tests in FY2025
- ~48% gross margin
- ~2% volume growth YoY
- 35%+ regional market share
- ~USD 95M operating cash flow
- Funds ~60% of fixed costs
Nomi Health's FY25 cash cows: $713M revenue mix-high margins, low capex winners
Nomi Health's FY2025 cash cows: Public-sector contracts $150M revenue (~18% OM); Legacy Artemis $200M recurring (~35% EBITDA); Mobile Hubs 50%+ niche share, low capex; TPA services $68M revenue (42% GM); Labs 4.2M tests, ~$95M OCFF, 48% GM.
| Line | FY2025 | Margin/Notes |
|---|---|---|
| Public contracts | $150M | ~18% OM |
| Legacy Artemis | $200M | ~35% EBITDA |
| Mobile Hubs | 200+ units | 50%+ share |
| TPA services | $68M | 42% GM |
| Labs | 4.2M tests | $95M OCFF, 48% GM |
Preview = Final Product
Nomi Health BCG Matrix
The file you're previewing is the exact Nomi Health BCG Matrix report you'll receive after purchase-no watermarks, no placeholders-just a fully formatted, analysis-ready document tailored for strategic clarity.
This preview matches the downloadable BCG Matrix file you'll get post-purchase, crafted with market-backed insights and ready to be edited, printed, or presented to stakeholders.
Once purchased, the same precise document shown here is delivered to your inbox-professionally designed for immediate use in planning, pitches, or portfolio review.
What you see is the final product: a one-time purchase grants instant access to the complete Nomi Health BCG Matrix for practical application without surprises.
Original: $10.00
-65%$10.00
$3.50NOMI HEALTH BCG MATRIX TEMPLATE RESEARCH
Visual. Strategic. Downloadable.
Nomi Health's BCG Matrix preview highlights where its service lines and tech offerings may land-potential Stars in care delivery, Cash Cows in established payment solutions, or Question Marks in newer digital ventures-offering a quick snapshot of strategic priorities. This is just a taste; purchase the full BCG Matrix for quadrant-by-quadrant placement, data-backed recommendations, and a ready-to-use Word + Excel package that turns analysis into actionable investment and operational decisions.
Stars
Direct Network Expansion with 550+ Henry Ford Sites
Nomi Health's late-2025 partnership with Henry Ford Health expands direct network reach to 550+ Henry Ford sites, enabling its direct-contracting model to serve 10,000+ enrolled lives with $0 deductibles in Michigan and bypass insurers, driving rapid share gains in the $1 trillion U.S. self-insured employer market.
Nomi Connect Fintech Platform
Nomi Connect Fintech Platform is the real-time payment rail Nomi Health uses to settle claims in days rather than months, driving transparency and faster cash flow for providers.
By late 2025 Nomi Connect processes roughly 40% of the $150 billion in healthcare spend influenced by Nomi Health, about $60 billion annually, showing high growth.
It ranks as a Star in Nomi Health's BCG matrix: high market share and market growth, locking providers and employers into the Nomi ecosystem through payments and settlement stickiness.
Mid-Market Employer Solutions (1,000-9,999 lives)
Nomi Health has seized a dominant share of mid-market employers (1,000-9,999 lives), where direct contracting adoption rose to 39% in 2025; this cohort delivers 15%-40% cost reductions per client, driving rapid revenue growth.
It's now Nomi's most aggressive growth segment and Star in the BCG matrix, but scaling demands heavy sales spend and regional infrastructure investment-sales OPEX rose ~28% YoY in 2025.
Integrated Analytics via Artemis Acquisition
Artemis by Nomi Health analyzes over 500 million claims annually and captured a leading employer-benefits analytics share in 2025, delivering the CFO-grade visibility companies demanded that year.
Its analytics unit is high-growth: Artemis is the gateway for employers shifting from traditional insurance, driving double-digit ARR growth and expanding enterprise penetration through 2025.
- Claims analyzed: 500+ million (2025)
- Role: primary visibility layer for CFOs in 2025
- Market position: commanding share in employer-benefits analytics
- Growth: double-digit ARR expansion as employers move off traditional insurance
State Bank Trust Charter Integration
Nomi Health obtained a State Bank trust charter in 2024 and fully scaled it by late 2025, enabling control of the banking leg of healthcare payments and shifting the company from payer-tech to healthcare-finance; this Star consumes roughly $120-150M cumulative compliance and capital runway costs but creates a first-to-market moat versus traditional providers.
The charter drives revenue leverage: projected 2025 payment float and interest income of $42M and a reduced per-claim cash-conversion cycle by 18 days, boosting EBITDA margin potential by ~4ppt over peers.
The Star requires ongoing regulatory and capital investment but offers high growth: management targets 30-40% ARR growth in 2026 via embedded-finance products and tighter unit economics that incumbents without banking control cannot replicate.
- Obtained 2024; scaled late 2025
- $120-150M capital/compliance spend to date
- $42M 2025 float/interest income (est.)
- 18-day faster cash conversion per claim
- 30-40% ARR growth target 2026
Nomi Health: $60B processed, $42M float, 500M claims-growth strong, $120-150M needed
Nomi Health's Stars: core units (Nomi Connect, Artemis, State Bank charter, mid-market direct contracting) drove ~$60B processed spend (2025), $42M payment float income, 30-40% 2026 ARR target, 28% sales OPEX rise (2025), 500M claims analyzed-high share and high growth but require $120-150M capital/compliance.
| Metric | 2025 |
|---|---|
| Processed spend | $60B |
| Payment float income | $42M |
| Claims analyzed | 500M+ |
| Sales OPEX change | +28% YoY |
| Capital/compliance to date | $120-150M |
| ARR growth target (2026) | 30-40% |
What is included in the product
Detailed Word Document
Concise BCG Matrix analysis of Nomi Health's units-Stars, Cash Cows, Question Marks, Dogs-with investment, hold, or divest guidance.
Customizable Excel Spreadsheet
One-page BCG Matrix placing Nomi Health units into quadrants for quick strategic clarity and executive decision-making.
Cash Cows
Public Sector & Government Testing Contracts
Nomi Health's pandemic-era public sector contracts-serving millions in Utah, Texas, and Florida-remain a steady cash cow, generating about $150 million in 2025 revenue and ~18% operating margin, with low marketing spend due to entrenched state relationships.
Self-Funded Employer Analytics (Legacy Artemis)
The Self-Funded Employer Analytics (Legacy Artemis) is a mature, high-margin cash cow covering a 20 million-life footprint and generating roughly $180-220M in 2025 recurring revenue, with EBITDA margins near 35%, funding debt service and Direct Network expansion.
Mobile Health Hub Infrastructure
Nomi Health's Mobile Health Hub Infrastructure-200+ mobile units serving 3,200+ customers-has transitioned from COVID response to routine screenings and immunizations, generating steady revenue from community health fairs and employer pop-ups.
With >50% market share in the niche mobile-as-a-service sector and low incremental capex, hubs deliver high margins and predictable cash flow, qualifying as a Cash Cow in Nomi Health's BCG matrix.
Third-Party Administrator (TPA) Support Services
Nomi Health's Third-Party Administrator (TPA) Support Services delivers back-end payment rails to TPAs, avoiding rebuilds and driving high-margin fees from an existing tech stack; in FY2025 this mature line contributed about $68M revenue with ~42% gross margin.
Low annual market growth (~3% healthcare payments) but Nomi holds an estimated 25% share in TPA-integrated payment tooling-classic Cash Cow: stable cash, limited expansion upside.
- FY2025 revenue: $68,000,000
- Gross margin: ~42%
- Market growth: ~3% CAGR (healthcare payments)
- Estimated market share in TPA tooling: ~25%
Laboratory Diagnostic Services
Laboratory Diagnostic Services at Nomi Health operates seven US-owned labs, processing ~4.2 million tests in FY2025 and delivering gross margins near 48%, making testing a stable cash cow as volume growth stabilized to ~2% YoY while regional market share exceeds 35% in key corridors.
These labs fund and stabilize Nomi's direct-care expansion, covering ~60% of group-wide fixed costs and producing ~USD 95M in operating cash flow in 2025.
- 7 owned labs
- ~4.2M tests in FY2025
- ~48% gross margin
- ~2% volume growth YoY
- 35%+ regional market share
- ~USD 95M operating cash flow
- Funds ~60% of fixed costs
Nomi Health's FY25 cash cows: $713M revenue mix-high margins, low capex winners
Nomi Health's FY2025 cash cows: Public-sector contracts $150M revenue (~18% OM); Legacy Artemis $200M recurring (~35% EBITDA); Mobile Hubs 50%+ niche share, low capex; TPA services $68M revenue (42% GM); Labs 4.2M tests, ~$95M OCFF, 48% GM.
| Line | FY2025 | Margin/Notes |
|---|---|---|
| Public contracts | $150M | ~18% OM |
| Legacy Artemis | $200M | ~35% EBITDA |
| Mobile Hubs | 200+ units | 50%+ share |
| TPA services | $68M | 42% GM |
| Labs | 4.2M tests | $95M OCFF, 48% GM |
Preview = Final Product
Nomi Health BCG Matrix
The file you're previewing is the exact Nomi Health BCG Matrix report you'll receive after purchase-no watermarks, no placeholders-just a fully formatted, analysis-ready document tailored for strategic clarity.
This preview matches the downloadable BCG Matrix file you'll get post-purchase, crafted with market-backed insights and ready to be edited, printed, or presented to stakeholders.
Once purchased, the same precise document shown here is delivered to your inbox-professionally designed for immediate use in planning, pitches, or portfolio review.
What you see is the final product: a one-time purchase grants instant access to the complete Nomi Health BCG Matrix for practical application without surprises.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Visual. Strategic. Downloadable.
Nomi Health's BCG Matrix preview highlights where its service lines and tech offerings may land-potential Stars in care delivery, Cash Cows in established payment solutions, or Question Marks in newer digital ventures-offering a quick snapshot of strategic priorities. This is just a taste; purchase the full BCG Matrix for quadrant-by-quadrant placement, data-backed recommendations, and a ready-to-use Word + Excel package that turns analysis into actionable investment and operational decisions.
Stars
Direct Network Expansion with 550+ Henry Ford Sites
Nomi Health's late-2025 partnership with Henry Ford Health expands direct network reach to 550+ Henry Ford sites, enabling its direct-contracting model to serve 10,000+ enrolled lives with $0 deductibles in Michigan and bypass insurers, driving rapid share gains in the $1 trillion U.S. self-insured employer market.
Nomi Connect Fintech Platform
Nomi Connect Fintech Platform is the real-time payment rail Nomi Health uses to settle claims in days rather than months, driving transparency and faster cash flow for providers.
By late 2025 Nomi Connect processes roughly 40% of the $150 billion in healthcare spend influenced by Nomi Health, about $60 billion annually, showing high growth.
It ranks as a Star in Nomi Health's BCG matrix: high market share and market growth, locking providers and employers into the Nomi ecosystem through payments and settlement stickiness.
Mid-Market Employer Solutions (1,000-9,999 lives)
Nomi Health has seized a dominant share of mid-market employers (1,000-9,999 lives), where direct contracting adoption rose to 39% in 2025; this cohort delivers 15%-40% cost reductions per client, driving rapid revenue growth.
It's now Nomi's most aggressive growth segment and Star in the BCG matrix, but scaling demands heavy sales spend and regional infrastructure investment-sales OPEX rose ~28% YoY in 2025.
Integrated Analytics via Artemis Acquisition
Artemis by Nomi Health analyzes over 500 million claims annually and captured a leading employer-benefits analytics share in 2025, delivering the CFO-grade visibility companies demanded that year.
Its analytics unit is high-growth: Artemis is the gateway for employers shifting from traditional insurance, driving double-digit ARR growth and expanding enterprise penetration through 2025.
- Claims analyzed: 500+ million (2025)
- Role: primary visibility layer for CFOs in 2025
- Market position: commanding share in employer-benefits analytics
- Growth: double-digit ARR expansion as employers move off traditional insurance
State Bank Trust Charter Integration
Nomi Health obtained a State Bank trust charter in 2024 and fully scaled it by late 2025, enabling control of the banking leg of healthcare payments and shifting the company from payer-tech to healthcare-finance; this Star consumes roughly $120-150M cumulative compliance and capital runway costs but creates a first-to-market moat versus traditional providers.
The charter drives revenue leverage: projected 2025 payment float and interest income of $42M and a reduced per-claim cash-conversion cycle by 18 days, boosting EBITDA margin potential by ~4ppt over peers.
The Star requires ongoing regulatory and capital investment but offers high growth: management targets 30-40% ARR growth in 2026 via embedded-finance products and tighter unit economics that incumbents without banking control cannot replicate.
- Obtained 2024; scaled late 2025
- $120-150M capital/compliance spend to date
- $42M 2025 float/interest income (est.)
- 18-day faster cash conversion per claim
- 30-40% ARR growth target 2026
Nomi Health: $60B processed, $42M float, 500M claims-growth strong, $120-150M needed
Nomi Health's Stars: core units (Nomi Connect, Artemis, State Bank charter, mid-market direct contracting) drove ~$60B processed spend (2025), $42M payment float income, 30-40% 2026 ARR target, 28% sales OPEX rise (2025), 500M claims analyzed-high share and high growth but require $120-150M capital/compliance.
| Metric | 2025 |
|---|---|
| Processed spend | $60B |
| Payment float income | $42M |
| Claims analyzed | 500M+ |
| Sales OPEX change | +28% YoY |
| Capital/compliance to date | $120-150M |
| ARR growth target (2026) | 30-40% |
What is included in the product
Detailed Word Document
Concise BCG Matrix analysis of Nomi Health's units-Stars, Cash Cows, Question Marks, Dogs-with investment, hold, or divest guidance.
Customizable Excel Spreadsheet
One-page BCG Matrix placing Nomi Health units into quadrants for quick strategic clarity and executive decision-making.
Cash Cows
Public Sector & Government Testing Contracts
Nomi Health's pandemic-era public sector contracts-serving millions in Utah, Texas, and Florida-remain a steady cash cow, generating about $150 million in 2025 revenue and ~18% operating margin, with low marketing spend due to entrenched state relationships.
Self-Funded Employer Analytics (Legacy Artemis)
The Self-Funded Employer Analytics (Legacy Artemis) is a mature, high-margin cash cow covering a 20 million-life footprint and generating roughly $180-220M in 2025 recurring revenue, with EBITDA margins near 35%, funding debt service and Direct Network expansion.
Mobile Health Hub Infrastructure
Nomi Health's Mobile Health Hub Infrastructure-200+ mobile units serving 3,200+ customers-has transitioned from COVID response to routine screenings and immunizations, generating steady revenue from community health fairs and employer pop-ups.
With >50% market share in the niche mobile-as-a-service sector and low incremental capex, hubs deliver high margins and predictable cash flow, qualifying as a Cash Cow in Nomi Health's BCG matrix.
Third-Party Administrator (TPA) Support Services
Nomi Health's Third-Party Administrator (TPA) Support Services delivers back-end payment rails to TPAs, avoiding rebuilds and driving high-margin fees from an existing tech stack; in FY2025 this mature line contributed about $68M revenue with ~42% gross margin.
Low annual market growth (~3% healthcare payments) but Nomi holds an estimated 25% share in TPA-integrated payment tooling-classic Cash Cow: stable cash, limited expansion upside.
- FY2025 revenue: $68,000,000
- Gross margin: ~42%
- Market growth: ~3% CAGR (healthcare payments)
- Estimated market share in TPA tooling: ~25%
Laboratory Diagnostic Services
Laboratory Diagnostic Services at Nomi Health operates seven US-owned labs, processing ~4.2 million tests in FY2025 and delivering gross margins near 48%, making testing a stable cash cow as volume growth stabilized to ~2% YoY while regional market share exceeds 35% in key corridors.
These labs fund and stabilize Nomi's direct-care expansion, covering ~60% of group-wide fixed costs and producing ~USD 95M in operating cash flow in 2025.
- 7 owned labs
- ~4.2M tests in FY2025
- ~48% gross margin
- ~2% volume growth YoY
- 35%+ regional market share
- ~USD 95M operating cash flow
- Funds ~60% of fixed costs
Nomi Health's FY25 cash cows: $713M revenue mix-high margins, low capex winners
Nomi Health's FY2025 cash cows: Public-sector contracts $150M revenue (~18% OM); Legacy Artemis $200M recurring (~35% EBITDA); Mobile Hubs 50%+ niche share, low capex; TPA services $68M revenue (42% GM); Labs 4.2M tests, ~$95M OCFF, 48% GM.
| Line | FY2025 | Margin/Notes |
|---|---|---|
| Public contracts | $150M | ~18% OM |
| Legacy Artemis | $200M | ~35% EBITDA |
| Mobile Hubs | 200+ units | 50%+ share |
| TPA services | $68M | 42% GM |
| Labs | 4.2M tests | $95M OCFF, 48% GM |
Preview = Final Product
Nomi Health BCG Matrix
The file you're previewing is the exact Nomi Health BCG Matrix report you'll receive after purchase-no watermarks, no placeholders-just a fully formatted, analysis-ready document tailored for strategic clarity.
This preview matches the downloadable BCG Matrix file you'll get post-purchase, crafted with market-backed insights and ready to be edited, printed, or presented to stakeholders.
Once purchased, the same precise document shown here is delivered to your inbox-professionally designed for immediate use in planning, pitches, or portfolio review.
What you see is the final product: a one-time purchase grants instant access to the complete Nomi Health BCG Matrix for practical application without surprises.
